Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Sep. 30, 2013
Dec. 31, 2012
Current assets:    
Cash $ 44,632,604 $ 9,118,564
Accounts receivable 157,826 17,605
Inventory 2,042,784 297,500
Prepaid expenses and other 790,156 1,183,714
Total current assets 47,623,370 10,617,383
Property and equipment 2,779,659 2,026,895
Less accumulated depreciation and amortization 1,400,559 1,092,317
Property and equipment, net 1,379,100 934,578
Patents and trademarks 143,370 115,053
Less accumulated amortization 25,523 22,571
Patents and trademarks, net 117,847 92,482
Deferred debt issuance costs and other 816,391 327,954
Total assets 49,936,708 11,972,397
Current liabilities:    
Accounts payable 1,704,945 1,417,463
Accrued liabilities and other 2,908,964 2,016,358
Notes payable, current, net of discounts of $727,265 and $202,287, respectively 1,692,091 2,756,718
Total current liabilities 6,306,000 6,190,539
Notes payable, net of discounts of $1,043,529 and $93,038, respectively 26,087,219 6,930,112
Derivative liabilities 7,675,446 0
Other liabilities 1,005,310 257,122
Total liabilities 41,073,975 13,377,773
Commitments and contingencies      
Stockholders’ equity (deficit):    
Preferred stock; $.001 par value; 5,000,000 shares authorized; 8,012 and 6,938 Series B shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively 8 7
Common stock; $.001 par value; 200,000,000 shares authorized; 134,345,483 and 113,018,772 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively 134,345 113,019
Additional paid-in capital 312,233,801 273,039,442
Accumulated deficit (303,505,421) (274,557,844)
Total stockholders’ equity (deficit) 8,862,733 (1,405,376)
Total liabilities and stockholders’ equity (deficit) $ 49,936,708 $ 11,972,397